title: Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
abstract: Loss of heterozygosity on chromosome 9p has been detected in many primary human tumors and cell lines, suggesting that this chromosomal arm harbors one or more tumor suppressor genes. The recently cloned p16 and p15 genes, mapped to 9p21, are likely candidates for such tumor suppressors. To map the deletion at chromosome 9p21 in non-small cell lung tumors, we analyzed DNA from 25 tumors and matching normal DNAs at six microsatellite markers that flank the region occupied by the p16 and p15 genes. Loss of heterozygosity of at least one microsatellite marker on chromosome 9p21 was detected in 13 (52%) of 25 tumors, including one tumor that exhibited homozygous deletion of both human IFNalpha and D9S171. Six tumors analyzed by a comparative multiplex PCR technique showed homozygous deletions of the sequence tag site marker c5.1 (within p16). Screening for mutations in p16 and p15 revealed one tumor with a non-sense mutation in exon 2 of p16, but no mutations were detected in p15 in any of the tumors. Thus, in these analyses approximately one-half of the non-small cell lung tumors had loss of heterozygosity at chromosome 9p21, and of these tumors, one-half had homozygous deletions of the region that includes p16. This appears to confirm the importance of a locus in this region critical to growth control in lung. The apparent lack of other mutations in p16 and p15 in the tumors with loss of heterozygosity leaves open the possibility of an unidentified gene in this region that may function as a tumor suppressor.
authors.affiliation: Environmental Carcinogenesis Program and Environmental Biology and Medicine Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA.
authors.forename: J P
authors.initials: JP
authors.lastname: Packenham
authors.forename: J A
authors.initials: JA
authors.lastname: Taylor
authors.forename: C M
authors.initials: CM
authors.lastname: White
authors.forename: C H
authors.initials: CH
authors.lastname: Anna
authors.forename: J C
authors.initials: JC
authors.lastname: Barrett
authors.forename: T R
authors.initials: TR
authors.lastname: Devereux
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics; D018196:Carcinoma, Adenosquamous / Q000235:genetics; D018287:Carcinoma, Large Cell / Q000235:genetics; D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics* / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000235:genetics; D018797:Cell Cycle Proteins; D002872:Chromosome Deletion; D002874:Chromosome Mapping; D002899:Chromosomes, Human, Pair 9; D050762:Cyclin-Dependent Kinase Inhibitor p15; D004252:DNA Mutational Analysis; D016147:Genes, Tumor Suppressor; D019942:Genes, p16; D005819:Genetic Markers; D006720:Homozygote; D006801:Humans; D016898:Interferon-alpha / Q000235:genetics; D008175:Lung Neoplasms / Q000235:genetics* / Q000473:pathology; D016133:Polymerase Chain Reaction; D016324:Sequence Tagged Sites; D014157:Transcription Factors / Q000235:genetics*; D025521:Tumor Suppressor Proteins
chemical_list: C493966:CDKN2B protein, human; D018797:Cell Cycle Proteins; D050762:Cyclin-Dependent Kinase Inhibitor p15; D005819:Genetic Markers; D016898:Interferon-alpha; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins